Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
5.81
-0.09 (-1.53%)
Nov 20, 2024, 4:00 PM EST - Market closed
Galecto Market Cap
Galecto has a market cap or net worth of $7.65 million as of November 21, 2024. Its market cap has decreased by -54.77% in one year.
Market Cap
7.65M
Enterprise Value
-11.99M
1-Year Change
-54.77%
Ranking
Category
Stock Price
$5.81
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has decreased from $368.78M to $7.65M, a decrease of -97.93%. That is a compound annual growth rate of -61.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 7.77M | -60.20% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | 316.01M | -14.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Virax Biolabs Group | 8.29M |
| Mustang Bio | 8.22M |
| XWELL | 8.09M |
| Cardio Diagnostics Holdings | 8.06M |
| ATI Physical Therapy | 7.99M |
| NeuroMetrix | 7.64M |
| Coeptis Therapeutics Holdings | 7.59M |
| Evoke Pharma | 7.40M |